Purchase Order 75N95020P00636
Award Date 9/16/20
Potential Completion Date 6/15/22
Potential Value $355K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02139, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute on Drug Abuse awarded a $2.96 million firm fixed-price purchase order to Oxford Nanopore Technologies Inc. on September 14, 2020, for the delivery of long-read sequencing kits to support the Laboratory of Neurogenetics' neurodegenerative disease research initiatives. The contract, which was completed on November 13, 2020, involved no set-aside designation and specified performance at Oxford Nanopore's Cambridge, Massachusetts location. Oxford Nanopore Technologies Inc.,...
- This $6,678 firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company that develops and provides nanopore-based electronic DNA/RNA sequencing systems. The award does not have a set-aside designation. Through this contract, Oxford Nanopore is providing its next-generation sequencing equipment, consumables, and...
- Oxford Nanopore Technologies Inc. received a $95,605 firm fixed-price purchase order (Contract #GRD-CAPEX) from a civilian Southeast Area federal agency for genomic sequencing equipment and services, with performance in Cambridge, Massachusetts. The contract was awarded on September 5, 2019, with an ultimate completion date of October 4, 2019. This award was not associated with a small business set-aside designation. Oxford Nanopore Technologies Inc., a foreign-owned biotechnology firm...
- This firm-fixed-price purchase order was awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency within the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The $15,040 contract is for the provision of Oxford Nanopore's proprietary library preparation kits and flow cells for long-read DNA/RNA sequencing to support ongoing NIDCD research projects. This award...
- This federal contract award, valued at $44,838.00, was made by the National Institute on Aging (NIA), a civilian agency under the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the procurement of Promethion flow cell packs and ligation sequencing kits, which are used in Oxford Nanopore's next-generation genomic sequencing platforms. The contract is a firm fixed-price purchase order with a...
- This contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, is for a software license and device warranty. The $13,500.00 firm fixed-price purchase order was awarded by the National Cancer Institute, a civilian agency within the National Institutes of Health (NIH). The contract will provide Oxford Nanopore's next-generation genomic sequencing products and services to support various research initiatives through February 1, 2026. Oxford Nanopore has...
- This federal contract award was issued by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The $16,500 firm-fixed-price purchase order is for the delivery of Oxford Nanopore's next-generation genomic sequencing equipment, consumables, reagents, software licenses, and associated services. The contract does not have a set-aside designation. Oxford Nanopore Technologies Inc....
- This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, provides a software license and device warranty for two GridION instruments to support the Food and Drug Administration's (FDA) next-generation sequencing efforts. The $25,000.00 firm-fixed-price purchase order has a period of performance through September 27, 2025. Oxford Nanopore Technologies is a provider of innovative nanopore-based sequencing platforms, which have been...
- This is a firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for $21,588.00 in equipment. The contract has no set-aside designation. Oxford Nanopore Technologies Inc. is a biotechnology company that develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins. The company has...
- This is a $12,550.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the license and warranty of a GridION sequencing device, with an ultimate completion date of August 1, 2025. Oxford Nanopore Technologies has secured numerous federal contract awards to supply next-generation genomic sequencing equipment, consumables, and associated...